|
| 37947157 | A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104). | Cancer | 2024 |
| 36305841 | Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer. | CA Cancer J Clin | 2023 |
| 37620627 | Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial. | Nat Med | 2023 |
| 37768653 | Virtual Tumor Board to Foster Interinstitutional Head and Neck Cancer Subspecialty Care. | JAMA Otolaryngol Head Neck Surg | 2023 |
| 37099979 | Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity. | Oral Oncol | 2023 |
| 37266942 | Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial. | JAMA Netw Open | 2023 |
| 36479637 | Biomarkers predictive of response to pembrolizumab in head and neck cancer. | Cancer Med | 2023 |
| 36399698 | Assessment of Oncology Patient Engagement and Interest in Virtual Mind-Body Programming: Moving Toward Personalization of Virtual Care. | JCO Oncol Pract | 2023 |
| 36689229 | Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma. | JAMA Netw Open | 2023 |
| 35050342 | Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy. | JAMA Oncol | 2022 |
| 35737363 | Comparison of Objective Measures of Trismus and Salivation With Patient-Reported Outcomes Following Treatment for Head and Neck Cancer. | JAMA Otolaryngol Head Neck Surg | 2022 |
| 35544650 | Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis. | JCO Oncol Pract | 2022 |
| 35521657 | A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer. | Thyroid | 2022 |
| 35620018 | Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process. | Clin Transl Radiat Oncol | 2022 |
| 36483055 | Correlation of an Electronic Geriatric Assessment With Receipt of Adjuvant Radiation and Chemotherapy in Older Adults With Head and Neck Cancer. | Adv Radiat Oncol | 2022 |
| 36367724 | Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. | JAMA Netw Open | 2022 |
| 35045748 | Enhancing Radioiodine Incorporation in <i>BRAF</i>-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial. | Thyroid | 2022 |
| 35276673 | NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. | J Natl Compr Canc Netw | 2022 |
| 35339025 | Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus-related malignancies. | Oral Oncol | 2022 |
| 29419566 | Risk Factors for Adverse Events in Patients With Breast, Colorectal, and Lung Cancer. | J Patient Saf | 2021 |
| 33586179 | Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center. | Int J Cancer | 2021 |
| 34436930 | ChemoPalRx-A Mobile App That Enhances Chemotherapy Prescription Accuracy: A Cross-Sectional Study. | JCO Clin Cancer Inform | 2021 |
| 34585389 | Therapeutic strategies for systemic therapies of human papillomavirus-related oropharyngeal cancer. | J Surg Oncol | 2021 |
| 34131915 | Should upfront surgery routinely be the treatment of choice for locoregionally advanced hypopharyngeal cancer in 2021? | J Surg Oncol | 2021 |
| 34265800 | IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome. | Am J Surg Pathol | 2021 |
| 33429428 | Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial. | J Natl Cancer Inst | 2021 |
| 33107986 | Case study of the integration of electronic patient-reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities. | Cancer | 2021 |
| 32822275 | Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma. | J Clin Oncol | 2021 |
| 31609479 | Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer. | Int J Cancer | 2020 |
| 31678634 | A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma. | Int J Radiat Oncol Biol Phys | 2020 |
| 32634781 | Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2020 |
| 32818509 | Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas. | Hum Pathol | 2020 |
| 32639615 | The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer. | Cancer | 2020 |
| 32135508 | Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and Concepts. | J Natl Compr Canc Netw | 2020 |
| 30643254 | Tumor mutational load predicts survival after immunotherapy across multiple cancer types. | Nat Genet | 2019 |
| 30256977 | Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers. | J Clin Endocrinol Metab | 2019 |
| 31174237 | Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer. | Cancer | 2019 |
| 31487684 | Engaging Community-Based Cancer Physicians: Experience of the Memorial Sloan Kettering Cancer Center Cancer Alliance. | J Natl Compr Canc Netw | 2019 |
| 30939095 | Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma. | J Clin Oncol | 2019 |
| 29172863 | Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. | J Clin Oncol | 2018 |
| 30421835 | Long-term quality of life in older patients with HPV-related oropharyngeal cancer. | Head Neck | 2018 |
| 29752322 | NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. | J Natl Compr Canc Netw | 2018 |
| 29522275 | Patterns of recurrence in oral tongue cancer with perineural invasion. | Head Neck | 2018 |
| 29436304 | Challenges and Opportunities for Developing New Therapeutics for Salivary Gland Cancers. | J Oncol Pract | 2018 |
| 28963790 | Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer. | Head Neck | 2018 |
| 29300804 | A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). | Ann Oncol | 2018 |
| 27442865 | The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform. | JAMA Oncol | 2017 |
| 28328302 | Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study. | J Clin Oncol | 2017 |
| 28493366 | Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. | J Pathol | 2017 |
| 28095173 | Performance of a Trigger Tool for Identifying Adverse Events in Oncology. | J Oncol Pract | 2017 |